---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-241077"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T11:48:03.923903+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences SPAC issues $800K convertible promissory note to Duksung Co., Ltd.

## Summary
- Principal $800K, 5% simple interest; 7% if prepaid after March 31, 2025.
- Automatically converts into common stock at $8.10/share upon Qualified PIPE closing (min $1.5M).
- Qualified PIPE must occur before or simultaneously with business combination with OSR Holdings.
- Maturity October 15, 2025; no prepayment before March 31, 2025 unless PIPE fails.
- Note includes trust account waiver and escrow of 400K shares by BCM Europe AG.

## SEC filing metadata
- accession: 0001193125-24-241077
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524241077/0001193125-24-241077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524241077/d842341d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-241077
- JSON: https://secwatch.observer/filing/0001193125-24-241077.json
- Plain text: https://secwatch.observer/filing/0001193125-24-241077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.